Galdiero Stefania, Falanga Annarita, Vitiello Mariateresa, Grieco Paolo, Caraglia Michele, Morelli Giancarlo, Galdiero Massimiliano
Department of Pharmacy, University of Naples "Federico II", Via Mezzocannone 16, and Via Domenico Montesano 49, 80100, Napoli, Italy; Centro Interuniversitario di Ricerca sui Peptidi Bioattivi, University of Naples "Federico II", Via Mezzocannone 16, 80134, Napoli, Italy; Istituto di Biostrutture e Bioimmagini - CNR, Via Mezzocannone 16, 80134, Napoli, Italy; DFM Scarl, Via Mezzocannone 16, 80134, Napoli, Italy.
J Pept Sci. 2014 Jul;20(7):468-78. doi: 10.1002/psc.2649. Epub 2014 May 30.
Nanotechnology is an expanding area of study with potentially pivotal applications in a discipline as medicine where new biomedical active molecules or strategies are continuously developing. One of the principal drawbacks for the application of new therapies is the difficulty to cross membranes that represent the main physiological barrier in our body and in all living cells. Membranes are selectively permeable and allow the selective internalization of substances; generally, they form a highly impermeable barrier to most polar and charged molecules, and represent an obstacle for drug delivery, limiting absorption to specific routes and mechanisms. Viruses provide attracting suggestions for the development of targeted drug carriers as they have evolved naturally to deliver their genomes to host cells with high fidelity. A detailed understanding of virus structure and their mechanisms of entry into mammalian cells will facilitate the development and analysis of virus-based materials for medical applications.
纳米技术是一个不断扩展的研究领域,在医学等学科中具有潜在的关键应用,新的生物医学活性分子或策略正在该领域持续发展。新疗法应用的主要缺点之一是难以穿过细胞膜,细胞膜是我们身体和所有活细胞中的主要生理屏障。细胞膜具有选择性渗透性,允许物质选择性内化;一般来说,它们对大多数极性和带电分子形成高度不可渗透的屏障,并且是药物递送的障碍,将吸收限制在特定途径和机制。病毒为靶向药物载体的开发提供了诱人的思路,因为它们已经自然进化,能够将其基因组高保真地递送至宿主细胞。深入了解病毒结构及其进入哺乳动物细胞的机制将有助于开发和分析用于医学应用的基于病毒的材料。